Faslodex (Fulvestrant Injection) : Astrazeneca Pharma vs. Chia Tai Tianqing Pharmaceutical Group
Wuxi Biologics has confirmed its intention to go public in an IPO application that reveals the contracter has seen revenue double and profits increase three-fold since 2014.